Litcius/Paper detail

Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity

Xixi Lin, Guixin Yuan, Bin Yang, Chun‐Lan Xie, Zhigao Zhou, Ying Liu, Zhijuan Liu, Zuoxing Wu, Yoshie Akimoto, Na Li, Ren Xu, Fangming Song

2024Phytomedicine16 citationsDOI

Topics & Concepts

RANKLOsteoclastBone resorptionOvariectomized ratChemistryBone remodelingIn vivoWestern blotOsteolysisOsteoporosisCancer researchIn vitroCell biologyInternal medicineMedicineReceptorBiochemistryBiologyActivator (genetics)BiotechnologySurgeryHormoneGeneBone Metabolism and DiseasesBone health and osteoporosis researchBone health and treatments
Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity | Litcius